We all know that surgical site infections (SSIs) are the ultimate nightmare in orthopedics. A flawlessly executed procedure can be completely undone in days by a microscopic layer of bacteria. With antibiotic resistance rising and hospital margins shrinking under bundled payment risks, our industry has desperately needed a real, preventative hardware solution.
But traditional coatings have historically stalled out—hindered by localized toxicity risks, fragile materials that chip during insertion, or staggering premium price tags that hospital value analysis committees (VACs) reject instantly.
That paradigm is about to break.
Watch/Listen to Paul Chirico explain the science of Silver Bullet Therapeutics here - https://youtu.be/geIbfjlE-2w
Most of the industry views antimicrobial hardware as an expensive, niche specialty product reserved only for high-risk revision cases. They are looking at this backward.
What Silver Bullet has built isn’t just an elegant piece of surface engineering; it is a textbook commercial arbitrage model designed to exploit modern healthcare economics. By engineering a manufacturing process that coats standard hardware for just a few dollars, they are int...
